DR. DANIELE PIOMELLI
Dr. Daniele Piomelli will deliver the Mechoulam Lecture at the Cannabis Research Conference 2021. Dr. Raphel Mechoulam, for whom the lecture series is named, recommended Dr. Piomelli for this honor. Dr. Piomelli is a Distinguished Professor of Anatomy and Neurobiology and Louise Turner Arnold Chair in Neurosciences at the University of California, Irvine.
He is co-director of UCI’s Center for the Study of Cannabis and Editor-in-Chief of Cannabis and Cannabinoid Research, a journal dedicated to studying cannabis, its derivatives, and their endogenous counterparts in the human body.
Daniele Piomelli studied pharmacology and neuroscience with James H. Schwartz and Eric Kandel at Columbia University (1983-1988), and with Paul Greengard at the Rockefeller University (1988-1990). In 2000, two of his mentors (Kandel and Greengard) were awarded the Nobel Prize for their contributions to physiology and medicine. Daniele is an author of more than 400 peer-reviewed articles in journals such as Nature, Science, Nature Medicine, PNAS, and Nature Neuroscience, three full-length books, and 34 patents. He founded the department of drug discovery and development (D3) at the Italian Institute of Technology in Genoa (Italy), which he directed from 2007 to 2016, and three biopharmaceutical start-ups based on discoveries made in his lab.
Dr. Marilyn A. Huestis will serve as the Opening Plenary speaker for the Cannabis Research Conference 2021. Dr. Huestis brings an extraordinary breadth and depth in clinical and forensic toxicology, anti-doping, diagnostic screening and confirmation drug testing, and cannabinoid agonists and antagonists.
Through her research, she focused on improving people’s lives by reducing deaths from drugged driving, finding novel medications to treat drug dependence and using drug testing as a tool for drug dependence treatment. Her research encompassed the mechanisms of action of cannabinoid agonists and antagonists, effects of in utero drug exposure, and the neurobiology and pharmacokinetics of novel psychoactive substances.
She has published 474 peer-reviewed manuscripts and book chapters, and more than 800 abstracts were presented at national and international meetings. ational Commission on Forensic Sciences before its termination. She is past president of the Society of Forensic Toxicologists, past Chair of the Toxicology Section of the American Academy of Forensic Sciences, and past president of The International Association of Forensic Toxicologists.